Search

everythinglearnresearchcommunity

for

Search:↓

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Irisin can promote hair growth by activating a specific signaling pathway.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

A new compound shows promise as a topical treatment for hair loss.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Overexpressing Tβ4 in cashmere goats improves hair fiber traits and increases cashmere yield.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Using tretinoin and hydroquinone can speed up the fading of skin pigmentation.

The combination therapy was effective and well-tolerated, especially in young patients.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.